ArticleHead & neck2021

PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance.

Neil E Bhola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.